Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.640.790.981.081.73

What is the latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS is 0.64 based on Mar2024 Standalone results.
Year Fixed Capital/Sales
Mar20240.64
Mar20230.79
Mar20220.98
Mar20211.08
Mar20201.73

How is Fixed Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.64
-18.99
Mar2023 0.79
-19.39
Mar2022 0.98
-9.26
Mar2021 1.08
-37.57
Mar2020 1.73 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹172.4 Cr -9.7% -7.6% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -3.4% -0.2% 18.1% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.3% 3.4% 55.5% Stock Analytics
CIPLA ₹119,410.0 Cr -2.6% -0.6% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -2.3% -2.1% 20.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -2.9% -0.2% -8.7% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-9.7%

-7.6%

-26.1%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses